(Q46953231)

26 December 2017

title

Significance of thymidylate synthase gene expression level in patients with adenocarcinoma of the lung (English)

1 reference

26 December 2017

1 reference

Hiroshi Hashimoto

1

1 reference

26 December 2017

Yuichi Ozeki

2

1 reference

26 December 2017

Mitsuharu Sato

3

1 reference

26 December 2017

Kiyohaya Obara

4

1 reference

26 December 2017

Noriyuki Matsutani

5

1 reference

26 December 2017

Yoshinori Nakagishi

6

1 reference

26 December 2017

Toshiro Ogata

7

1 reference

26 December 2017

Tadaaki Maehara

8

1 reference

26 December 2017

language of work or name

English

0 references

publication date

1 April 2006

1 reference

26 December 2017

published in

Cancer

1 reference

26 December 2017

volume

106

1 reference

26 December 2017

page(s)

1595-1601

1 reference

26 December 2017

issue

7

1 reference

26 December 2017

Tumor extension and cell proliferation in adenocarcinomas of the lung

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21777

Thymidylate synthase expression and activity: relation to S-phase parameters and 5-fluorouracil sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21777

Identification of a thymidylate synthase ribonucleoprotein complex in human colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21777

Thymidylate synthase as a translational regulator of cellular gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21777

Adjuvant chemotherapy after complete resection in non-small-cell lung cancer. West Japan Study Group for Lung Cancer Surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21777

7 January 2021

Thymidylate synthetase: mechanism of inhibition by 5-fluoro-2'-deoxyuridylate.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21777

7 January 2021

The role of thymidylate synthase expression in prognosis and outcome of adjuvant chemotherapy in patients with rectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21777

7 January 2021

Prognostic importance of thymidylate synthase expression in early breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21777

7 January 2021

Prognostic of DNA-synthesizing enzyme activities (thymidine kinase and thymidylate synthase) in 908 T1-T2, N0-N1, M0 breast cancers: a retrospective multicenter study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21777

7 January 2021

Immunohistochemical evaluation of thymidylate synthase in gastric carcinoma using a new polyclonal antibody: the clinical role of thymidylate synthase as a prognostic indicator and its therapeutic usefulness.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21777

7 January 2021

DNA-synthesizing enzymes in breast cancer (thymidine kinase, thymidylate synthase and thymidylate kinase): association with flow cytometric S-phase fraction and relative prognostic importance in node-negative premenopausal patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21777

7 January 2021

Prognostic value of thymidylate synthase expression in patients with p-stage I adenocarcinoma of the lung

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21777

7 January 2021

Thymidylate synthase and dihydropyrimidine dehydrogenase activities in non-small cell lung cancer tissues: relationship with in vitro sensitivity to 5-fluorouracil

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21777

7 January 2021

Thymidylate synthase protein expression and activity are related to the cell proliferation rate in human cancer cell lines.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21777

7 January 2021

Clinical significance of thymidylate synthase expression in bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21777

7 January 2021

Investigation of the prognostic and predictive value of thymidylate synthase, p53, and Ki-67 in patients with locally advanced colon cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21777

7 January 2021

Revisions in the International System for Staging Lung Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21777

7 January 2021

Quantitation of dihydropyrimidine dehydrogenase expression by real-time reverse transcription polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21777

7 January 2021

Thymidylate synthase expression in epithelial ovarian cancer: relationship with thymidine phosphorylase expression and prognosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21777

7 January 2021

Prognostic significance of thymidylate synthase activity in bladder carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21777

7 January 2021

Prognostic significance of the thymidylate biosynthetic enzymes in human colorectal tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21777

7 January 2021

New prognostic indicator for non-small-cell lung cancer, quantitation of thymidylate synthase by real-time reverse transcription polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21777

7 January 2021

The role of thymidylate synthase as an RNA binding protein

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21777

7 January 2021

Thymidylate synthase and drug resistance

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21777

7 January 2021

Thymidylate synthase inhibitors in cancer therapy: direct and indirect inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21777

7 January 2021

A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21777

7 January 2021

Identifiers

DOI

10.1002/CNCR.21777

1 reference

26 December 2017

PubMed ID

16489621

1 reference

26 December 2017